HMT, such as protein arginine N-methyltransferase 1 (PRMT1) and MYND domain containing 3 (SMYD3), have been described to favor M2 polarization and, as such, represent targets to inhibit accumulation of tumor-promoting TAM (18–24). This evidence concerns the gene PRMT1 and neoplasm.